VICTORIA, CANADA. Several studies have shown that schizophrenics tend to smoke far more than other
people and yet lung cancer rates are much lower than in the general population whether smokers or not.
Drs. Abram Hoffer and Harold Foster now propose a fascinating hypothesis to explain this phenomenon. Dr.
Hoffer MD, a practicing psychiatrist, has treated some 4000 schizophrenic patients since 1952 and observed
that only one per cent of them also had cancer. Dr. Foster, a medical geographer, has found that
schizophrenics tend to have very low levels of selenium and the body's natural antioxidant, glutathione
peroxidase.
Drs. Hoffer and Foster now propose that schizophrenia is associated with high blood levels of the
hallucinogen adrenochrome, which is formed by oxidation of adrenaline (epinephrine). The low antioxidant
status of schizophrenics worsens their condition because they are unable to prevent the oxidation. The
excessive conversion of adrenaline to adrenochrome tends to make schizophrenic patients adrenaline
deficient. This in turn may explain why they tend to smoke more - nicotine increases adrenaline turnover in
the brain. Thus smoking may actually be a form of self-medication.
Dr. Hoffer has had excellent results by treating schizophrenics with high doses of niacin (vitamin B3) and
ubiquinone (coenzyme Q10) which both lower elevated adrenochrome levels. To explain the abnormally low cancer rates among schizophrenia patients Drs. Hoffer and Foster suggest
that elevated adrenochrome levels may protect against tumor development. Parnate, an antidepressant,
encourages adrenochrome production and has halted at least one case of brain cancer. A new drug,
Intradose, which contains cisplatin and adrenaline, is currently being tested with excellent results in the
treatment of liver cancer. Dr. Hoffer speculates that cisplatin, a powerful oxidant, rapidly converts the
adrenaline to adrenochrome which then destroys or at least contains the liver tumor. The Intradose gel is
injected directly into the tumor. |